In dextran sulfate sodium (DSS)-induced colitis in a mouse model, IL-13–/– mice administered DSS exhibited significantly reduced colitis severity compared to that of wild-type (WT) mice, accompanied by downregulation of ECs number and colonic 5-HT content. This evidence concerns the gene IL13 and colitis.